Fundraising Fox
Milestone Pharmaceuticals
Montreal, US · Founded 2007 · Quebec, Canada corporation · 130 employees on LinkedIn · 5 known investors
Find your way into Milestone Pharmaceuticals
Sign up to see every warm intro you have to Milestone Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Milestone Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.
Founders & leadership
Board
Investors · 5
How we know: Pappas Capital's portfolio page · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$90.7M disclosed across 3 rounds · 2015–2018
▶$80MraisedOct 2018 · 16 investors · PharmaceuticalsRule 506(b)
- Guy RousseauExecutive Officer
- Nilesh KumarDirector
- Debra LiebertDirector
- Paul TruexDirector
- Francis PlatExecutive Officer
- Joseph G. OlivetoExecutive Officer, Director
- Douglas WightExecutive Officer
- Philippe DouvilleExecutive Officer
- Marco BoorsmaDirector
- Harish PimplaskarExecutive Officer
- Lorenz MullerExecutive Officer
- Jeff NelsonExecutive Officer
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Oct 2018
- Incorporated
- Corporation, Quebec, Canada
- Federal exemptions
- 06b
▶$6.9MraisedJul 2017 · 5 investors · PharmaceuticalsRule 506(b)
- Dion MadsenDirector
- Scott WeinerDirector
- Philippe DouvilleExecutive Officer
- Guy RousseauExecutive Officer
- Nilesh KumarDirector
- Francis PlatExecutive Officer
- Paul TruexDirector
- Douglas WightExecutive Officer
- Debra LiebertDirector
- Marco BoorsmaDirector
- Martin MaguireExecutive Officer
- Yves RosconiDirector
- Joseph G. OlivetoExecutive Officer, Director
- Offering amount
- $6.9M
- Amount sold
- $6.9M
- First sale
- Jul 2017
- Incorporated
- Corporation, Quebec, Canada
- Federal exemptions
- 06b
▶$3.8MraisedJun 2015 · 3 investors · PharmaceuticalsRule 506(b)
- Debra LiebertDirector
- Ela BorensteinDirector
- Francis PlatExecutive Officer
- Yves RosconiDirector
- Scott WeinerDirector
- Martin MaguireExecutive Officer
- Philippe DouvilleExecutive Officer, Director
- Nathalie BeauregardExecutive Officer
- Benjamin CowenExecutive Officer
- Douglas WightExecutive Officer
- Paul TruexExecutive Officer, Director
- Offering amount
- $9.4M
- Amount sold
- $3.8M
- First sale
- Jun 2015
- Incorporated
- Corporation, Canada (federal Level)
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Milestone Pharmaceuticals went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Milestone Pharmaceuticals.
In the news
Frequently asked questions
- What does Milestone Pharmaceuticals do?
- Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.
- Who are Milestone Pharmaceuticals's investors?
- Milestone Pharmaceuticals's investors include Pappas Capital, Amplitude Venture Capital, Domain Associates, Forbion, RTW Investments L.P..
- How much funding has Milestone Pharmaceuticals raised?
- Milestone Pharmaceuticals has disclosed $90.7M raised across 3 rounds.
- Where is Milestone Pharmaceuticals headquartered?
- Milestone Pharmaceuticals is headquartered in Montreal, US.